Considerations for the accelerated acceptance of new approach methodologies (NAMs) and in-vitro alternatives for product testing and development

Biopharma, chemical and other companies seeking to develop new products or compounds face the challenge of navigating complex animal research regulations and routine ethical considerations. Many are opting for innovations in conducting research that replaces or reduces animal use while still meeting regulatory requirements and ensuring product safety